Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Hits Target Forecast With 19.33% Profit: A Success Story for QuantWave

February 01, 2024
ELI LILLY AND COMPANY has successfully reached the price target forecast set by QuantWave, resulting in a profit of 19.33% for investors. The forecast signal date was 2023-11-01 when the price stood at 546.58 $. The predicted direction was long, and on 2024-02-01, the stock reached a price of 652.25 $.

This achievement highlights the accuracy and effectiveness of QuantWave's analytics in predicting stock movement. The market analysis suggests that factors such as positive earnings reports, new drug developments, and overall market optimism contributed to the upward trajectory of ELI LILLY AND COMPANY's stock.

QuantWave's automated forecasting platform continues to provide users with valuable insights and opportunities for potential profits across a wide range of stocks. For those interested in enhancing their investment strategy, QuantSchool offers comprehensive educational resources that reveal the key principles for generating consistent income using the QuantWave forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 8, 2025ELI LILLY AND COMPANY Hits Price Target Forecast with 18.31% Profit - QuantWave Achieves Success Once Again  ~2 min.

ELI LILLY AND COMPANY, one of the leading pharmaceutical companies, recently saw its stock price hitting the forecasted target with a profit of 18.31% as predicted by QuantWave on June 4, 2025....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 20.09% Profit: QuantWave Achieves Success  ~1 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was trading at 800.2 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits QuantWave Forecast, Delivering 19.57% Profit  ~1 min.

ELI LILLY AND COMPANY has achieved the price target forecast set by QuantWave, signaling a 19.57% profit for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast as QuantWave Users Gain 17.38% Profit  ~1 min.

ELI LILLY AND COMPANY stock recently achieved the price target forecast set by QuantWave, marking a significant success for users of the automated forecasting platform....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Target Forecast with 17.25% Profit: A Success Story for QuantWave  ~2 min.

ELI LILLY AND COMPANY, a leading pharmaceutical company, recently saw its stock hit the target forecast set by QuantWave, yielding a profit of 17.25%....


LLYAugust 7, 2025ELI LILLY AND COMPANY Hits Forecast Profit of 23.55%: A Success Story for QuantWave  ~2 min.

ELI LILLY AND COMPANY, a prominent player in the pharmaceutical industry, recently achieved a significant milestone by hitting a price target forecast generated by the innovative forecasting platform, QuantWave. The forecast, which indicated a short direction signal on April 17, 2025, at a price of 836.4 USD, proved to be accurate as the stock reached the predicted target price of 639.46 USD on Au...


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Target Forecast with 22.13% Profit  ~1 min.

ELI LILLY AND COMPANY stock successfully reached the forecasted target price of 639.46 $ on August 7, 2025, resulting in a profit of 22.13% for investors....


LLYAugust 1, 2025Eli Lilly and Company Completes Acquisition of Verve Therapeutics, Advancing One-Time Treatments for High Cardiovascular Risk  ~1 min.

Eli Lilly and Company has announced the successful completion of its acquisition of Verve Therapeutics, a move that will help advance innovative one-time treatments for individuals with high cardiovascular risk. This strategic decision showcases the company's commitment to revolutionizing the healthcare industry and improving patient outcomes. Investors are eagerly watching as Eli Lilly continues ...


LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....


SLBSeptember 5, 2023QuantWave Achieves 72.17% Profit Target Forecast for SCHLUMBERGER LIMITED  ~1 min.

QuantWave, the automated forecasting platform, successfully reached a price target forecast for the stock SCHLUMBERGER LIMITED, with a profit of 72.17%....


CVXOctober 27, 2023QuantWave Achieves 5.08% Profit Target Forecast for Chevron Corporation  ~1 min.

QuantWave, the automated forecasting platform, has successfully hit its price target forecast for Chevron Corporation's stock....


AMZNNovember 6, 2024QuantWave Achieves 16.15% Profit Target Forecast for AMAZON.COM, INC.  ~1 min.

QuantWave, the automated forecasting platform, has successfully reached its price target forecast for AMAZON.COM, INC. The forecast signal was issued on March 26, 2024, when the stock was trading at $178....


TDSOctober 18, 2024TELEPHONE AND DATA SYSTEMS, INC. Hits Price Target Forecast with 32.48% Profit  ~1 min.

On July 16, 2024, QuantWave issued a forecast signal for TELEPHONE AND DATA SYSTEMS, INC. with a predicted direction of long and a price of 21.93 $....


UNHApril 2, 2024UNITEDHEALTH GROUP INCORPORATED Hits 9.56% Profit Target as Forecasted by QuantWave  ~1 min.

On September 25, 2023, QuantWave's automated forecasting platform generated a short signal for UNITEDHEALTH GROUP INCORPORATED, with a price target of $450.93....